| |
|
|
|
|
|
|
|
Content |
|
Key Issue:
- The amount of carotid
plaque mirrors your risk for stroke and myocardial infarction. Only by
having the information of TPA in your carotid arteries it becomes in general
possible to decide, how agressively your risk for stroke and myocardial
infarction should be treated.
- Do not use calcium
scoring first. Use TPA, it's so much easier.
|
|
 |
|
|
7 TPA High Light Issues |
|
What You need to Know about
TPA |
|
|
|
| |
|
|
|
|
|
|
What is TPA |
|
- TPA is a measure of
atherosclerosis and the total plaque burden within your carotid arteries.
|
|
|
|
| |
|
|
|
|
|
|
What can TPA |
|
- TPA is a completely
safe ultrasound based test which says more than many other test in
medicine with regard to your risk for myocardial infarction and stroke
with a diagnostic accuracy of around 77% (area under the curve AUC), and
this test takes only 2-5 minutes!
- TPA will replace in
most patients calcium scoring with its inherent radiation burden
- TPA is used to track
atherosclerotic disease. This serves to better treat the Nr 1 killer of
humanity.
|
|
|
|
| |
|
|
|
|
|
|
Aims |
|
- Improved and earlier
detection of atherosclerosis
|
|
|
|
| |
|
- Targeted prevention -
not every one with elevated cholesterol needs a statin !
|
|
|
|
| |
|
- Help GP's to better
prevent sequalae of atherosclerosis in their primary care patients
|
|
|
|
| |
|
- Communication of the
need to use TPA
|
|
|
|
| |
|
- Generation of a large
scientific and financial base for TPA measurements in Switzerland
|
|
|
|
| |
|
|
. |
|
|
|
TPA integration in clinical
management of atherosclerosis
Diagnostic Strategies
 |
|
- For every given
pretest probability, e.g. assessed by PROCAM or SCORE, the TPA posttest
probability for your 10 year risk can be precisely calculated using the
Bayes formula. This way of posttest risk calculation is revolutionary in
medicine and was developed by Kardiolab in order to compare ROC curves of
tests predictive of vascular events.
|
|
|
TPA Risk Categories in
mm2 (simplified) |
|
|
0-9 low |
|
|
10-49 intermediate |
|
|
50-99 high |
|
|
over 100 very high |
|
|
|
| |
|
|
|
|
|
|
What do we need TPA for |
|
- better assessment of
the true risk for AMI and STROKE
|
|
|
|
| |
|
- more convincing to
change bad habits, when images are used instead of words
|
|
|
|
| |
|
- helps to reassess
your risk as being high instead of intermediate or low
|
|
|
|
| |
|
- better assessment of
the need for lipid lowering drungs
|
|
|
|
| |
|
- helps stop smoking
faster
|
|
|
|
| |
|
- can be used for
atherosclerosis tracking: in case of plaque growth, a closer look at
cardiovascular risk factors is needed.
|
|
|
|
| |
|
- number needed to
treat in intervention studies: per group and year only about 60 persons
needed (for IMT: about 400 personen needed).
|
|
|
|
| |
|
|
|
|
|
|
TPA: our data |
|
- Comparison of TPA and
calcium scores in the same person: helps to answer the question, in which
cases TPA may replace calcium scoring. Data on file Kardiolab, N about
400.
|
|
|
|
| |
|
- TPA and vascular
morbidity and mortality: assessment of correlations. Data on file
Kardiolab, N about 1000
|
|
|
|
| |
|
- Comparison of IMT and
TPA with conventional risk factors. Data on file Kardiolab, N about 225.
|
|
|
|
| |
|
- TPA used on a
practice based level for atherosclerosis tracking, N about 700 with
follow-up of 1-5 years.
|
|
|
|
| |
|
|
|
|
|
|
TPA: what we need for the
future |
|
- trained MDs and
Assistents from Angiology, Neurology, Angiology, Cardiology ecc) with TPA certificates.
|
|
|
|
| |
|
- More comparative
studies, e.g. with IMT or the newly developed Atherosclerosis Burden Score
(ABS: CHUV, Prof. Darioli)
|
|
|
|
| |
|
- centralized national
data pool for TPA, constant monitoring of TPA test performance for outcome
data
|
|
|
|
| |
|
|
|
 |
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|